Journal Article10.1067/MCP.2002.121829
Changes in plasma protein binding have little clinical relevance.
Leslie Z. Benet,Betty-Ann Hoener +1 more
789
TL;DR: It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for use in the neonatal intensive care unit based on prior history and once they provide informed consent for surgery.
read more
Abstract: Clinical Pharmacology & Therapeutics (2002) 71, 115–121; doi: 10.1067/mcp.2002.121829
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
When and How to Apply ADMET Principles to Drug Discovery and Development
Dennis A. Smith
- 15 Oct 2012
TL;DR: The chapter provides a framework for designing screening strategies which include ADMET and list important criteria to be considered in defining probabilities of project success.
•Dissertation
Translational research in tuberculosis: crossing barriers between molecular and clinical pharmacology
L.H.M. te Brake
- 01 Jan 2016
TL;DR: The role of efflux transporters in TB drug handling is reviewed, the promise ofefflux pump inhibition from a novel holistic perspective is evaluated, and the emergence of phenotypic tolerance and drug resistance is evaluated.
Multiobjective Optimization of Biological and Physical Properties in Drug Discovery
M.P. Gleeson,D. Montanari +1 more
- 01 Jan 2017
TL;DR: Whether as an industry the authors have become overly focused on properties or metrics that are within their understanding and control, even though they know they are of finite relevance, is discussed.
Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B
TL;DR: PPB is an effective parameter for defining clearance rate determination for acidic and zwitterionic drugs with high MWs and is used as an additional parameter in ECCS, clearance mechanisms for class 1B and 3B compounds can be predicted, and OATP and Oat substrates may be readily distinguished.
Lack of drug interaction between cyclosporine and telaprevir in a liver transplant recipient.
Florian Lemaitre,C. Jezequel,Marie-Clémence Verdier,Marie-Clémence Verdier,M. Dermu,M. Dermu,C. Boglione‐Kerrien,Karim Boudjema,Karim Boudjema,Eric Bellissant,Eric Bellissant +10 more
TL;DR: The case of an unpredictable lack of interaction between CsA and telaprevir in a liver transplant recipient and the mechanism leading to this lack of drug interaction in this patient has not been fully elucidated yet is likely to affect the absorption phase.
References
Simultaneous Modeling of Pharmacokinetics and Pharmacodynamics: Application to D-Tubocurarine
TL;DR: A model of drug pharmacodynamic response that when integrated with a pharmacokinetic model allows characterization of the temporal aspects of pharmacodynamics as well as the time-independent sensitivity component and can accommodate extremes of effect is proposed.
637
•Book
Basic clinical pharmacokinetics
Michael E. Winter
- 01 Jan 1980
TL;DR: Basic clinical pharmacokinetics /, Basic clinical Pharmacokinetics , کتابخانه دیجیتال جندی شاپور اهواز
379
Potentiation of Anticoagulant Effect of Warfarin by Phenylbutazone
TL;DR: The administration of the pyrazolone derivatives, phenylbutazone and oxyphen butazone, to a patient already being treated with coumarin anticoagulant drugs can lead to serious hemorrhagic complications.
231